Arkolith/Insider Trading/CERO/Form 4

YK Bioventures Opportunities GP I, LLC

10% OwnerCERO THERAPEUTICS HOLDINGS, INC. (CERO) · full profile →Form 4 · filed Dec 13, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$400K
Net Open-Market Flow
-$400K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2024Sell(S)3.0M$0.06$180K13.0M
Dec 12, 2024Sell(S)1.6M$0.07$113K16.0M
Dec 11, 2024Sell(S)1.3M$0.08$108K17.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-029371) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML